Insider Trading activities of Exelixis, Inc. insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Exelixis, Inc. since 2005. The reporting company's ticker symbol is EXEL. The reporting company's CIK number is 939767.
The total value of stock buying since 2005 is $3,904,031.
The total value of stock sales since 2005 is $89,063,543.
The total value of stock option exercises since 2005 is $25,002,707.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Exelixis, Inc. insiders (EXEL) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-08-31 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 132,662 9.73 1,290,801
2016-08-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 42,338 11.00 465,718
2016-08-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 42,338 9.73 411,948
2016-06-01 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 200,000 1.70 340,000
2016-05-11 Willsey Lance Buy 20,000 4.95 99,000
2016-05-09 Willsey Lance Buy 40,000 4.97 198,920
2015-12-11 Willsey Lance Buy 50,000 4.78 239,000
2015-12-10 Willsey Lance Buy 50,000 4.99 249,549
2015-11-16 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 2,083 .00 0
2015-11-16 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 3,125 .00 0
2015-10-16 Lamb Peter (EVP, Discovery Research & CSO) Sale 51,549 5.80 298,984
2015-10-16 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 51,549 5.63 290,220
2015-10-13 Lamb Peter (EVP, Discovery Research & CSO) Sale 600 5.80 3,480
2015-10-13 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 600 5.63 3,378
2015-10-12 Lamb Peter (EVP, Discovery Research & CSO) Sale 300,276 5.84 1,753,311
2015-10-12 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 300,276 5.63 1,690,553
2014-11-15 Burke Deborah (SVP & Chief Financial Officer) Option Ex 6,438 .00 0
2014-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 2,083 .00 0
2014-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 3,125 .00 0
2014-09-17 Marchesi Vincent T (Director) Buy 20,000 1.71 34,200
2014-02-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,126 .00 0
2014-02-15 Karbe Frank (EVP and CFO) Option Ex 1,954 .00 0
2014-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2014-02-15 Simonton Pamela A (EVP, Exelixis) Option Ex 1,875 .00 0
2014-02-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 5,208 .00 0
2013-11-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 5,312 .00 0
2013-11-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-11-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-08-29 Willsey Lance (Director) Buy 10,000 5.14 51,400
2013-08-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,125 .00 0
2013-08-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-08-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2013-08-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-08-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-05-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,124 .00 0
2013-05-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-05-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,187 .00 0
2013-05-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-05-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-02-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,126 .00 0
2013-02-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2013-02-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-02-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2012-12-20 Marchesi Vincent T (Director) Buy 4,000 4.68 18,720
2012-12-19 Marchesi Vincent T (Director) Buy 1,500 4.67 7,005
2012-12-18 Marchesi Vincent T (Director) Buy 1,500 4.82 7,230
2012-12-17 Marchesi Vincent T (Director) Buy 3,000 4.70 14,091
2012-12-10 Schwab Gisela (EVP and Chief Medical Officer) Buy 25,000 4.39 109,749
2012-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 5,209 .00 0
2012-11-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2012-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 5,312 .00 0
2012-11-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2012-11-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2012-08-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,125 .00 0
2012-08-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2012-08-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2012-08-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2012-08-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2012-06-14 Marchesi Vincent T (Director) Sale 7,000 5.13 35,917
2012-05-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,124 .00 0
2012-05-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2012-05-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,187 .00 0
2012-05-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2012-05-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2012-02-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,126 .00 0
2012-02-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2012-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2012-02-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2012-02-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2011-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,125 .00 0
2011-11-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2011-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,187 .00 0
2011-11-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2011-11-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2011-08-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,125 .00 0
2011-08-15 Rivera Lupe M (EVP, Operations) Option Ex 2,578 .00 0
2011-08-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2011-08-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2011-08-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2011-08-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2011-05-15 Heller Frances K (EVP, Business Development) Option Ex 3,125 .00 0
2011-05-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,124 .00 0
2011-05-15 Rivera Lupe M (EVP, Operations) Option Ex 3,828 .00 0
2011-05-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2011-05-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,187 .00 0
2011-05-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2011-05-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2011-02-15 Heller Frances K (EVP, Business Development) Option Ex 12,500 .00 0
2011-02-15 Lamb Peter (EVP. Discovery Research) Option Ex 12,500 .00 0
2011-02-15 Rivera Lupe M (EVP, Operations) Option Ex 12,813 .00 0
2011-02-15 Karbe Frank (Executive VP and CFO) Option Ex 7,813 .00 0
2011-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 8,750 .00 0
2011-02-15 Simonton Pamela A (EVP and General Counsel) Option Ex 7,500 .00 0
2011-02-15 Morrissey Michael (President and CEO) Option Ex 12,500 .00 0
2010-12-17 Rivera Lupe M (EVP, Operations) Sale 29,427 8.50 250,129
2010-12-17 Rivera Lupe M (EVP, Operations) Option Ex 29,427 5.03 147,870
2010-12-15 Rivera Lupe M (EVP, Operations) Sale 50,000 7.67 383,350
2010-12-15 Rivera Lupe M (EVP, Operations) Option Ex 50,000 5.63 281,500
2010-12-14 Rivera Lupe M (EVP, Operations) Sale 25,000 7.00 175,000
2010-12-14 Rivera Lupe M (EVP, Operations) Option Ex 25,000 5.63 140,750
2010-12-09 Schwab Gisela (EVP & Chief Medical Officer) Sale 4,112 6.50 26,728
2010-09-07 Willsey Lance Buy 21,078 3.67 77,356
2010-09-03 Willsey Lance Buy 15,122 3.51 53,047
2010-08-30 Willsey Lance Buy 71,300 3.16 225,379
2010-08-27 Willsey Lance Buy 28,700 3.25 93,418
2010-08-24 Karbe Frank (EVP & CFO) Buy 16,500 2.98 49,170
2010-08-24 Papadopoulos Stelios Buy 200,000 3.06 611,600
2010-08-16 Willsey Lance Buy 53,600 2.88 154,636
2010-08-13 Willsey Lance Buy 46,400 2.94 136,648
2010-08-13 Morrissey Michael (President & CEO) Buy 30,000 2.95 88,500
2009-12-24 Rivera Lupe M (SVP, Operations) Sale 9,375 8.00 75,000
2009-12-24 Rivera Lupe M (SVP, Operations) Option Ex 9,375 5.04 47,250
2009-12-16 Rivera Lupe M (SVP, Operations) Sale 3,125 7.56 23,625
2009-12-16 Rivera Lupe M (SVP, Operations) Option Ex 3,125 5.04 15,750
2009-11-02 Heller Frances K (EVP, Business Development) Sale 2,529 6.19 15,657
2009-06-03 Heller Frances K (EVP, Business Development) Sale 10,609 5.01 53,140
2009-06-03 Schwab Gisela (EVP & Chief Medical Officer) Sale 8,197 5.00 41,025
2008-10-31 Karbe Frank (EVP, CFO) Buy 7,500 3.35 25,125
2008-10-31 Willsey Lance Buy 50,000 3.40 170,050
2008-10-30 Karbe Frank (EVP, CFO) Buy 10,000 3.23 32,250
2008-10-30 Scangos George A (President & CEO) Buy 25,000 3.20 80,000
2008-10-30 Papadopoulos Stelios Buy 300,000 3.23 968,700
2008-03-17 Rivera Lupe M (SVP, Operations) Sale 2,213 4.98 11,014
2008-02-27 Scangos George A (President & CEO) Sale 2,500 6.54 16,357
2008-02-22 Scangos George A (President & CEO) Sale 2,500 5.86 14,640
2008-02-13 Scangos George A (President & CEO) Sale 2,500 7.05 17,632
2008-02-06 Scangos George A (President & CEO) Sale 2,500 6.87 17,172
2008-01-28 Scangos George A (President & CEO) Sale 5,000 7.13 35,660
2008-01-23 Scangos George A (President & CEO) Sale 2,500 7.10 17,752
2008-01-18 Scangos George A (President & CEO) Sale 2,500 7.66 19,147
2008-01-07 Scangos George A (President & CEO) Sale 2,500 8.41 21,035
2007-12-31 Scangos George A (President & CEO) Sale 2,500 8.67 21,669
2007-12-24 Scangos George A (President & CEO) Sale 2,500 9.24 23,090
2007-12-19 Scangos George A (President & CEO) Sale 2,500 9.09 22,717
2007-12-10 Scangos George A (President & CEO) Sale 2,500 8.64 21,589
2007-12-05 Scangos George A (President & CEO) Sale 2,500 8.80 21,995
2007-11-29 Scangos George A (President & CEO) Sale 2,500 8.85 22,115
2007-11-21 Scangos George A (President & CEO) Sale 2,500 8.13 20,337
2007-11-12 Scangos George A (President & CEO) Sale 2,500 9.18 22,940
2007-11-09 Scangos George A (President & CEO) Sale 2,500 11.31 28,267
2007-10-11 Cohen Charles Sale 8,125 12.06 97,987
2007-07-26 Scangos George A (President & CEO) Sale 2,500 10.20 25,502
2007-07-20 Scangos George A (President & CEO) Sale 2,500 11.38 28,462
2007-07-12 Scangos George A (President & CEO) Sale 2,500 11.64 29,107
2007-07-06 Scangos George A (President & CEO) Sale 2,500 11.85 29,632
2007-07-02 Cohen Charles Sale 8,125 12.30 99,937
2007-06-29 Scangos George A (President & CEO) Sale 2,500 12.21 30,527
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.